Overview of Adverse Events Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
Ekaterina Vorozheikina, Magdalena Ruiz, Leticia Solari, Dmitry Ostasevich & Luis Mendoza · International Blood Research & Reviews · 2021
Anti-CD19 chimeric antigen receptor (CAR) T-cells represent a novel immunotherapy that has shown remarkable success in the treatment of adult relapsed or refractory (R/R) B-cell non-Hodgkin's lymphoma, adult R/R mantle cell lymphoma, and R/R acute paediatric lymphoblastic leukaem...
Open access
Research Article
10.9734/ibrr/2021/v12i430157